Cerebrospinal fluid biogenic amine metabolites, plasma‐rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Primary fibromyalgia syndrome (PFS) is a chronic disorder commonly seen in rheumatological practice. The pathophysiological disturbances of this syndrome, which was defined by the American College of Rheumatology in 1990, are poorly understood. This study evaluated, in 30 patients, the hypothesis that PFS is a pain modulation disorder induced by deregulation of serotonin metabolism. OBJECTIVES: To compare platelet [(3)H]imipramine binding sites and serotonin (5-HT) levels in plasma-rich platelets (PRP) of PFS patients with those of matched healthy controls and to compare the levels of biogenic amine metabolites in the cerebrospinal fluid (CSF) of PFS patients with those of matched controls. METHODS: Platelet [(3)H]imipramine binding sites were defined by two criteria, B(max) for their density and K(d) for their affinity. PRP 5-HT and CSF metabolites of 5-HT (5-hydroxyindoleacetic acid, 5-HIAA), norepinephrine (3-methoxy, 4-hydroxy phenylglycol, MHPG) and dopamine (homovanillic acid, HVA) were assayed by reversed-phase high-performance liquid chromatography with coulometric detection. RESULTS: [(3)H]Imipramine platelet binding was similar (P=0.43 for B(max) and P=0.30 for K(d)) in PFS patients (B(max)=901+/-83 fmol/mg protein, K(d)=0.682+/-0.046) and in matched controls (B(max)=1017+/-119 fmol/mg protein, K(d)=0.606+/-0.056). PRP 5-HT was significantly higher (P=0.0009) in PFS patients (955+/-101 ng/10(9) platelets) than in controls (633+/-50 ng/10(9) platelets). When adjusted for age, the levels of all CSF metabolites were lower in PFS patients. The CSF metabolite of norepinephrine (MHPG) was lower (P:=0.003) in PFS patients (8.33+/-0.33 ng/ml) than in matched controls (9.89+/-0.31 ng/ml) and 5-HIAA was lower (P=0.042) in PFS female patients (22.34+/-1.78 ng/ml) than in matched controls (25.75+/-1.75 ng/ml). For HVA in females, the difference between PFS patients (36.32+/-3.20 ng/ml) and matched controls (38.32+/-2.90 ng/ml) approached statistical significance (P=0.054). CONCLUSION: Changes in metabolites of CSF biogenic amines appear to be partially correlated to age but remained diagnosis-dependent. High levels of PRP 5-HT in PFS patients were associated with low CSF 5-HIAA levels in female patients but were not accompanied by any change in serotonergic uptake as assessed by platelet [(3)H]imipramine binding sites. These findings do not allow us to confirm that serotonin metabolism is deregulated in PFS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls
Yunus, M., Masi, A. T., Calabro, J. J., Miller, K. A., & Feigenbaum, S. L. (1981) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(81)90096-2 · Cited by 910
Elevated cerebrospinal fluid levels of substance p in patients with the fibromyalgia syndrome
Russell, I. J., Orr, M. D., Littman, B., Vipraio, G. A., Alboukrek, D., Michalek, J. E., Lopez, Y., & Mackillip, F. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371106 · Cited by 679
Vaerøy, H., Helle, R., Førre, Ø., Kåss, E., & Terenius, L. (1988) · Pain · doi:10.1016/0304-3959(88)90019-x · Cited by 421
Research works printed but not linked: 28
- Smythe HA. ‘Fibrositis’ as a disorder of pain modulation. Clin Rheum Dis1979;5:823–32. · DOI
- Wolfe F, Hawley D, Cathey MA. Fibrositis: symptoms, frequency and criteria for diagnosis. J Rheumatol1985; 12:1159–63.
- Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum1990;33:160–72. · DOI · Paper page
- Bartels EM, Danneskiold‐Samsoe B. Histological abnormalities in muscle from patients with certain types of fibrositis. Lancet1984;1:755–7. · DOI
- Bengtsson A, Henriksson KG, Larsson J. Muscle biopsy in primary fibromyalgia: light microscopal and histochemical findings. Scand J Rheumatol1986;15:1–6. · DOI · Paper page
- Moldofsky H, Warsh JJ. Plasma tryptophan and musculoskeletal pain in non‐articular rheumatism (‘fibrositis syndrome’). Pain1978;5:65–71. · DOI · Paper page
- Moldofsky H. Rheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system serotonin and pain. Adv Neurol1982;33:51–7.
- Murphy RM, Zemla FP. Differential effects of substance P on serotonin‐modulated spinal nociceptive reflexes. Psychopharmacology1987;93:118–21. · DOI
- Russel IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum1992; 35:550–6. · DOI · Paper page
- Russel IJ, Michalek JE, Vipraio GA, Flechter EM, Javors MA, Bowden CA. Platelet 3H‐imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol1992; 19:104–9.
- Mellerup E, Langer SZ. A World Health Organization collaborative study: Validity of imipramine platelet binding sites as a biological marker of endogenous depression. Pharmacopsychiatry1990;23:113–7. · doi:10.1055/s-2007-1014492
- Spreux‐Varoquaux O, Gailledreau J, Vanier B et al. Initial increase of plasma free serotonin: a biological predictor for the antidepressant response to clomipramine. Biol Psychiatry1996;40:465–73. · doi:10.1016/0006-3223(95)00449-1
- Matson WR, Langlais P, Volicer L, Gamache PH, Bird E, Mark KA. n‐Electrode three dimensional liquid chromatography with electrochemical detection for determination of neurotransmitter. Clin Chem1984;30:1477–88. · doi:10.1093/clinchem/30.9.1477
- Poirier MF, Benkelaft C, Loo H et al. Reduced Bmax of 3H‐imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors. Psychopharmacology1986;89:456–61. · DOI
- Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science1980;209:303–5. · DOI · Paper page
- Carsten ME, Engelbrecht AH, Russel VA et al. Imipramine binding sites on platelets of patients with major depressive disorder. Psychiatry Res1986;18:333–42. · DOI
- Owens MJ, Nemeroff CB. Role of the serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem1994;40:288–95. · DOI · Paper page
- Hudson JI, Hudson MB, Pliner LF, Goldenberg DL, Pope HG. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry1985;142:441–6. · DOI · Paper page
- Goldenberg DL. Psychiatric and psychological aspects of fibromyalgia syndrome. Rheum Dis Clin North Am1989;15:105–15. · DOI
- Ahles TA, Yunus MB, Masi AT. Is chronic pain a variant of depressive disease? The case of primary fibromyalgia syndrome. Pain1987;29:105–11. · DOI · Paper page
- Kravitz MH, Katz R, Kot E, Helmke N, Fawcett J. Biochemical clues to a fibromyalgia–depression link: imipramine binding in patients with fibromyalgia or depression and in healthy controls. J Rheumatol1992; 19:1428–32.
- Magni G, Andreoli F, Arduino C. 3H‐Imipramine binding sites are decreased in platelets of chronic pain patients. Acta Psychiatr Scand1987;75:108–10. · doi:10.1111/j.1600-0447.1987.tb02760.x
- Wolfe I, Russel IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold and fibromyalgia symptoms in the general population. J Rheumatol1997; 24:555–9.
- Schwarz MJ, Spath M, Muller‐Bardorff H, Pongratz DE, Bondy B, Ackenheil M. Relationship of substance P, 5‐hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett1999;259:196–8. · DOI
- Stratz T, Samborski W, Hrycaj P et al. Serum serotonin concentration in patients with generalized tendomyopathy (fibromyalgia) and rheumatoid arthritis. Med Klin1993; 88:458–62.
- Blennow K, Wallin A, Gottfries CG et al. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age. Eur Neuropsychopharmacol1993; 3:55–61. · DOI
- Bowers M, Gerbode F. The relationship of monoamine metabolite in human CSF to age. Nature1968; 219:1256–7. · DOI
- Gottfries CG, Gottfries I, Johansson B et al. Acid monoamine metabolites in human CSF and their relationship to age and gender. Neuropharmacology1971;10:665–72. · doi:10.1016/0028-3908(71)90081-5
Cited by
The association of sleep and pain: an update and a path forward
Finan, P. H., Goodin, B. R., & Smith, M. T. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2013.08.007 · Cited by 1,620
An internet survey of 2,596 people with fibromyalgia
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-27 · Cited by 865
Arnold, L. M., Rosen, A., Pritchett, Y. L., D'Souza, D. N., Goldstein, D. J., Iyengar, S., & Wernicke, J. F. (2005) · Pain · doi:10.1016/j.pain.2005.06.031 · Cited by 471
“Dysfunction in both serotonin and norepinephrine systems has been implicated in the etiology of fibromyalgia (Legangneux et al., 2001; Russell et al., 1992a,b; Yunus et al., 1992).”
BackgroundNeurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in Bioscience · doi:10.2741/3598 · Cited by 366
The comorbidity of insomnia, chronic pain, and depression: Dopamine as a putative mechanism
Finan, P. H., & Smith, M. T. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.03.003 · Cited by 363
Metadata
- Authors
- Legangneux, E., Mora, J. J., Spreux‐Varoquaux, O., Thorin, I., Herrou, M., Alvado, G., & Gomeni, C.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-03
- Volume
- 40
- Issue
- 3
- Pages
- 290-296
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2085189002
- Cited by
- 120
- References
- 3
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrospinal fluid biogenic amine metabolites, plasma‐rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. https://app.cochat.ai/papers/10.1093/rheumatology/40.3.290
- The paper
- Legangneux, E., Mora, J. J., Spreux‐Varoquaux, O., Thorin, I., Herrou, M., Alvado, G., & Gomeni, C. (2001). Cerebrospinal fluid biogenic amine metabolites, plasma‐rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology. https://doi.org/10.1093/rheumatology/40.3.290
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.